These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 13910655)

  • 1. [Chemotherapy of resistant infections by inhibition of bacterial urease].
    SENECA H
    Bull Acad Natl Med; 1962 Feb 20-27; 146():146-8. PubMed ID: 13910655
    [No Abstract]   [Full Text] [Related]  

  • 2. Bacterial urease inhibition chemotherapy in drug resistant infections.
    SENECA H
    J Med Liban; 1961; 14():392-9. PubMed ID: 13910654
    [No Abstract]   [Full Text] [Related]  

  • 3. Bacterial enzyme profiles and chemotherapy of drug-resistant infections.
    SENECA H; NALLY R; PEER P
    Antibiot Chemother; 1963; 11():180-93. PubMed ID: 13987954
    [No Abstract]   [Full Text] [Related]  

  • 4. Ureases as a target for the treatment of gastric and urinary infections.
    Follmer C
    J Clin Pathol; 2010 May; 63(5):424-30. PubMed ID: 20418234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-resistant bacteria made drug-susceptible by enzyme inhibitors.
    LATTIMER JK; SENECA H; ZINSSER HH; DONOVAN JT
    JAMA; 1961 Nov; 178():764-6. PubMed ID: 14462711
    [No Abstract]   [Full Text] [Related]  

  • 6. In vitro screening and evaluation of some Indian medicinal plants for their potential to inhibit Jack bean and bacterial ureases causing urinary infections.
    Bai S; Bharti P; Seasotiya L; Malik A; Dalal S
    Pharm Biol; 2015 Mar; 53(3):326-33. PubMed ID: 25366133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Urinary calculi and infection].
    Trinchieri A
    Urologia; 2014; 81(2):93-8. PubMed ID: 24874306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Acetylhydroxamic acid in the treatment of nephrolithiasis, caused by infection with urease forming microorganisms].
    Lorenz J; Lorenz K; Dabrowska B; Kowal R
    Z Urol Nephrol; 1989 Dec; 82(12):685-9. PubMed ID: 2698024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in bacterial enzyme patterns, drug susceptibility and chemotherapy through enzyme blocking agents.
    SENECA H; LATTIMER JK; ZINSSER JJ; DONOVAN JT; PEER P; STUART PH
    Trans Am Assoc Genitourin Surg; 1961; 53():188-95. PubMed ID: 13910650
    [No Abstract]   [Full Text] [Related]  

  • 10. In vitro studies on a new urease-blocking agent, N-(3-chloromercury-2-methoxypropyl)-5-methyl-3-isoxazole carboxamide.
    SENECA H; LATTIMER JK; PEER P; NALLY R
    Antibiot Chemother (Northfield); 1961 Nov; 11():715-23. PubMed ID: 13910648
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibition of urease by miscellaneous ions and compounds. Implications for the therapy of infection-induced urolithiasis.
    Burr RG
    Invest Urol; 1977 Sep; 15(2):180-2. PubMed ID: 903216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in bacterial enzyme patterns, drug susceptibility and chemotherapy through enzyme blocking agents.
    SENECA H; LATTIMER JK; ZINSSER HH; DONOVAN JT; PEER P; STUART PH
    J Urol; 1962 Mar; 87():495-8. PubMed ID: 13910649
    [No Abstract]   [Full Text] [Related]  

  • 13. A facile one-pot synthesis of 2-arylamino-5-aryloxylalkyl-1,3,4-oxadiazoles and their urease inhibition studies.
    Akhtar T; Khan MA; Iqbal J; Jones PG; Hameed S
    Chem Biol Drug Des; 2014 Jul; 84(1):92-8. PubMed ID: 24495281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitors of bacterial urease: microbiological considerations on hydroxyurea influenza virus.
    Perrone G; Ferrari C; Arghittu M
    Boll Ist Sieroter Milan; 1982; 61(6):513-5. PubMed ID: 6765400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Inhibition of urease activity by hydroxamic acid and its practical application].
    Kobashi K
    Seikagaku; 1972 May; 44(5):187-204. PubMed ID: 4559340
    [No Abstract]   [Full Text] [Related]  

  • 16. Plant-Derived Urease Inhibitors as Alternative Chemotherapeutic Agents.
    Hassan ST; Žemlička M
    Arch Pharm (Weinheim); 2016 Jul; 349(7):507-22. PubMed ID: 27244041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structurally diversified heterocycles and related privileged scaffolds as potential urease inhibitors: a brief overview.
    Ibrar A; Khan I; Abbas N
    Arch Pharm (Weinheim); 2013 Jun; 346(6):423-46. PubMed ID: 23712847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cysteine based novel noncompetitive inhibitors of urease(s)--distinctive inhibition susceptibility of microbial and plant ureases.
    Amtul Z; Kausar N; Follmer C; Rozmahel RF; Atta-Ur-Rahman ; Kazmi SA; Shekhani MS; Eriksen JL; Khan KM; Choudhary MI
    Bioorg Med Chem; 2006 Oct; 14(19):6737-44. PubMed ID: 16859909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis, molecular docking, anti-Proteus mirabilis and urease inhibition of new fluoroquinolone carboxylic acid derivatives.
    Abdullah MA; Abuo-Rahma GE; Abdelhafez EM; Hassan HA; Abd El-Baky RM
    Bioorg Chem; 2017 Feb; 70():1-11. PubMed ID: 27908539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of inhibition by fluoride of urease activities of cell suspensions and biofilms of Staphylococcus epidermidis, Streptococcus salivarius, Actinomyces naeslundii and of dental plaque.
    Barboza-Silva E; Castro AC; Marquis RE
    Oral Microbiol Immunol; 2005 Dec; 20(6):323-32. PubMed ID: 16238590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.